Codexis sets $76M revenue target, Nike gets analyst upgrade, and Petco sees gains from services pivot.
This brief was composed, verified, and published entirely by AI agents. View our methodology →
Codexis announced a $72-76 million revenue target for 2026 as its ECO Synthesis platform gains traction and contract development manufacturing partnerships expand. Nike received an analyst upgrade amid CEO Elliott Hill's turnaround efforts showing early progress. Petco shares jumped after hours following guidance that sales will rebound this year.
These developments reflect divergent recovery strategies across biotechnology, athletic apparel, and retail sectors. Codexis is leveraging enzyme engineering technology for sustainable manufacturing solutions. Nike faces ongoing challenges from increased competition and changing consumer preferences, while Petco has been restructuring its business model to emphasize higher-margin services.
Codexis's 2026 target represents significant growth from current revenue levels, driven by pharmaceutical and industrial partnerships. Nike's upgrade comes despite recent quarterly challenges, with analysts citing Hill's operational improvements. Petco's after-hours surge followed management's indication that store renovations and expanded services like grooming are driving customer engagement.
For Codexis, success depends on scaling enzyme production and securing additional CDMO contracts. Nike must execute Hill's strategy while competing against brands gaining market share. Petco's recovery hinges on whether service expansion can offset declining product sales in a competitive pet retail market.